BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240805
DTEND;VALUE=DATE:20240810
DTSTAMP:20260417T050743
CREATED:20240409T064209Z
LAST-MODIFIED:20240409T120736Z
UID:53838-1722816000-1723247999@www.braincouncil.eu
SUMMARY:IASP 2024 World Congress on Pain
DESCRIPTION:About IASP 2024 World Congress on PainIASP's World Congress on Pain is the largest gathering of pain professionals in the world\, bringing together more than 5\,000 scientists\, clinicians\, and healthcare providers from around the world and across pain disciplines. Attendees will experience a world-class lineup of more than 400 international speakers with comprehensive sessions bringing you the latest pain research and treatment. \nThe World Congress will include the IASP 50th Anniversary celebration with reflections on industry advances in pain research and IASP milestones over the last 50 years. Join IASP 5 – 9 August 2024 in Amsterdam to commemorate 50 years of working together for pain relief throughout the World. \nEBC will attend the Congress and will hold 3 poster presentation: \n\nHealth Gains and Socio-Economic Impacts of Multimodal Management of Diabetic Neuropathic Pain\nHealth Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Fibromyalgia Syndrome\nHealth Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Chronic Primary Low-Back Pain\n\nLEARN MORE AND REGISTER
URL:https://www.braincouncil.eu/event/iasp-2024-world-congress-on-pain/
LOCATION:Amsterdam\, The Netherlands
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/04/59ec1c1b87924a04983b63473d58d524_c6dd498835f30c6fce901dccefa94388.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240806T093000
DTEND;TZID=UTC:20240806T110000
DTSTAMP:20260417T050743
CREATED:20240409T065516Z
LAST-MODIFIED:20240730T120838Z
UID:53842-1722936600-1722942000@www.braincouncil.eu
SUMMARY:Health Gains and Socio-Economic Impacts of Multimodal Management of Diabetic Neuropathic Pain | IASP 2024 World Congress on Pain
DESCRIPTION:About the poster presentationEBC will hold a poster presentation at IASP 2024 World Congress on Pain on the topic “Health Gains and Socio-Economic Impacts of Multimodal Management of Diabetic Neuropathic Pain”. \nDiabetic neuropathic pain is one of the largest health burdens in countries around the globe. Pain specialists had developed a multimodal approach to chronic pain management in the 1980ies that leads to major improvements in functioning and quality of life and reduced work absenteeism. Multimodal pain management is offered by specialized clinics in some countries\, but is not generally available to the patient population at large. This is partly due to the consideration that it may be too expensive. Led by the European Brain Council within the Value of Treatment (VoT) initiative\, VoT Chronic Pain analysed to what extent the cost of multimodal management is offset by savings in direct and indirect cost of continuing the current standard of care.   \nThe aim of this study is to assess the cost-effectiveness of chronic pain management in one model country (Germany) with and without multimodal treatment in patients with diabetic neuropathic pain.  \nCome and participate in the IASP 2024 World Congress on Pain to delve into the findings of the study and interact with experts face-to-face to ask your questions! \nSpeakerMark Nuijten \nMark Nuijten\, PhD\, MD\, MBA\, is an Adjunct Professor at ITU\, a medical doctor\, health economist\, market access and pricing consultant\, valuation economist\, and healthcare policy journalist. He has a diverse career in the health academic and business environment\, collaborating with leading experts in health economics. \nNuijten is developing economic modelling in healthcare and finance. He’s a pioneer in healthcare innovation in biotechnology and nutrition\, and the first to apply and develop Discounted Cash Flow methodologies for biotechnology innovation valuation. His innovative concepts include the Pricing Matrix Model for early phase pricing and the Financial Valuation Algorithm for assessing future cash flows of new medicinal products. His reimbursement dossiers have contributed to positive reimbursement decisions by health authorities in many countries. \nHe supervises PhD programs at the Universities of Maastricht and Groningen in The Netherlands and is the founder of the ISPOR Special Interest Group on nutrition-economics. He is also an Adjunct Professor at ITU (Istanbul Technical University) in International Healthcare Assessment and Valuation. \nNuijten is a founding member of Minerva Health Economics Network\, Ltd. (MINERVA)\, an affiliation of independent health-economic consultancies and contract-research organizations. Before setting up A2M\, he was a partner with EVIDERA\, establishing global Pricing and Reimbursement Consultancy Services\, and was Managing Director of the IQVIA office in the Netherlands. \nNuijten trained as a physician before obtaining an international MBA from Erasmus University\, Rotterdam\, and a PhD in health economics. He has become a leading health economic expert\, with over 200 publications and leading positions in scientific societies and editorial boards. He was on the Board of Directors of ISPOR (2002-2004) and contributed to the first Dutch pharmaco-economic research guidelines and costing manual. \nLEARN MORE ABOUT VOT CHRONIC PAINLEARN MORE ABOUT THE CONGRESS
URL:https://www.braincouncil.eu/event/health-gains-and-socio-economic-impacts-of-multimodal-management-of-diabetic-neuropathic-pain-iasp-2024-world-congress-on-pain/
LOCATION:Amsterdam\, The Netherlands
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/04/59ec1c1b87924a04983b63473d58d524_c6dd498835f30c6fce901dccefa94388.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240806T093000
DTEND;TZID=UTC:20240806T110000
DTSTAMP:20260417T050743
CREATED:20240409T065913Z
LAST-MODIFIED:20240730T120902Z
UID:53843-1722936600-1722942000@www.braincouncil.eu
SUMMARY:Health Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Fibromyalgia Syndrome | IASP 2024 World Congress on Pain
DESCRIPTION:About the poster presentationEBC will hold a poster presentation at IASP 2024 World Congress on Pain on the topic “Health Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Fibromyalgia Syndrome“. \nFibromyalgia is one of the largest health burdens in countries around the globe. Pain specialists had developed a multimodal and interdisciplinary approach to chronic pain management in the 1980ies that leads to major improvements in functioning and quality of life and reduced work absenteeism. Structured interdisciplinary pain management is offered by specialized clinics in some countries\, but is not generally available to the patient population at large. This is partly due to the consideration that it may be too expensive. Led by the European Brain Council within the Value of Treatment (VoT) initiative\, VoT Chronic Pain analysed to what extent the cost of structured interdisciplinary management is offset by savings in direct and indirect cost of continuing the current standard of care.   \nThe aim of this study is to assess the cost-effectiveness of chronic pain management in a model country (Germany) with and without structured interdisciplinary treatment in patients with fibromyalgia.  \nCome and participate in the IASP 2024 World Congress on Pain to delve into the findings of the study and interact with experts face-to-face to ask your questions! \nSpeakerMark Nuijten \nMark Nuijten\, PhD\, MD\, MBA\, is an Adjunct Professor at ITU\, a medical doctor\, health economist\, market access and pricing consultant\, valuation economist\, and healthcare policy journalist. He has a diverse career in the health academic and business environment\, collaborating with leading experts in health economics. \nNuijten is developing economic modelling in healthcare and finance. He’s a pioneer in healthcare innovation in biotechnology and nutrition\, and the first to apply and develop Discounted Cash Flow methodologies for biotechnology innovation valuation. His innovative concepts include the Pricing Matrix Model for early phase pricing and the Financial Valuation Algorithm for assessing future cash flows of new medicinal products. His reimbursement dossiers have contributed to positive reimbursement decisions by health authorities in many countries. \nHe supervises PhD programs at the Universities of Maastricht and Groningen in The Netherlands and is the founder of the ISPOR Special Interest Group on nutrition-economics. He is also an Adjunct Professor at ITU (Istanbul Technical University) in International Healthcare Assessment and Valuation. \nNuijten is a founding member of Minerva Health Economics Network\, Ltd. (MINERVA)\, an affiliation of independent health-economic consultancies and contract-research organizations. Before setting up A2M\, he was a partner with EVIDERA\, establishing global Pricing and Reimbursement Consultancy Services\, and was Managing Director of the IQVIA office in the Netherlands. \nNuijten trained as a physician before obtaining an international MBA from Erasmus University\, Rotterdam\, and a PhD in health economics. He has become a leading health economic expert\, with over 200 publications and leading positions in scientific societies and editorial boards. He was on the Board of Directors of ISPOR (2002-2004) and contributed to the first Dutch pharmaco-economic research guidelines and costing manual. \nLEARN MORE ABOUT VOT CHRONIC PAINLEARN MORE ABOUT THE CONGRESS
URL:https://www.braincouncil.eu/event/health-gains-and-socio-economic-impacts-of-structured-interdisciplinary-management-of-fibromyalgia-syndrome-iasp-2024-world-congress-on-pain/
LOCATION:Amsterdam\, The Netherlands
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/04/59ec1c1b87924a04983b63473d58d524_c6dd498835f30c6fce901dccefa94388.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240806T093000
DTEND;TZID=UTC:20240806T110000
DTSTAMP:20260417T050743
CREATED:20240409T070239Z
LAST-MODIFIED:20240730T120751Z
UID:53844-1722936600-1722942000@www.braincouncil.eu
SUMMARY:Health Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Chronic Primary Low-Back Pain | IASP 2024 World Congress on Pain
DESCRIPTION:About the poster presentationEBC will hold a poster presentation at IASP 2024 World Congress on Pain on the topic "Health Gains and Socio-Economic Impacts of Structured Interdisciplinary Management of Chronic Primary Low-Back Pain". \nChronic primary low-back pain\, formerly called\, non-specific back pain\, is one of the largest health burdens in countries around the globe. Pain specialists had developed a structured multimodal and interdisciplinary approach to its management in the 1980ies that leads to major improvements in functioning and quality of life and reduced work absenteeism. Such management is offered by specialized clinics in some countries\, but is not generally available to the patient population at large. This is partly due to the consideration that it may be too expensive. Led by the European Brain Council within the Value of Treatment (VoT) initiative\, partners analysed to what extent the cost of structured interdisciplinary management is offset by savings in direct and indirect cost of the current standard of care.   \nThe aim of this study is to assess the cost-effectiveness of chronic pain management in one model country (Germany) with and without structured interdisciplinary treatment in patients with chronic low back pain.  \nCome and participate in the IASP 2024 World Congress on Pain to delve into the findings of the study and interact with experts face-to-face to ask your questions! \nSpeakerMark Nuijten \nMark Nuijten\, PhD\, MD\, MBA\, is an Adjunct Professor at ITU\, a medical doctor\, health economist\, market access and pricing consultant\, valuation economist\, and healthcare policy journalist. He has a diverse career in the health academic and business environment\, collaborating with leading experts in health economics. \nNuijten is developing economic modelling in healthcare and finance. He’s a pioneer in healthcare innovation in biotechnology and nutrition\, and the first to apply and develop Discounted Cash Flow methodologies for biotechnology innovation valuation. His innovative concepts include the Pricing Matrix Model for early phase pricing and the Financial Valuation Algorithm for assessing future cash flows of new medicinal products. His reimbursement dossiers have contributed to positive reimbursement decisions by health authorities in many countries. \nHe supervises PhD programs at the Universities of Maastricht and Groningen in The Netherlands and is the founder of the ISPOR Special Interest Group on nutrition-economics. He is also an Adjunct Professor at ITU (Istanbul Technical University) in International Healthcare Assessment and Valuation. \nNuijten is a founding member of Minerva Health Economics Network\, Ltd. (MINERVA)\, an affiliation of independent health-economic consultancies and contract-research organizations. Before setting up A2M\, he was a partner with EVIDERA\, establishing global Pricing and Reimbursement Consultancy Services\, and was Managing Director of the IQVIA office in the Netherlands. \nNuijten trained as a physician before obtaining an international MBA from Erasmus University\, Rotterdam\, and a PhD in health economics. He has become a leading health economic expert\, with over 200 publications and leading positions in scientific societies and editorial boards. He was on the Board of Directors of ISPOR (2002-2004) and contributed to the first Dutch pharmaco-economic research guidelines and costing manual. \nLEARN MORE ABOUT VOT CHRONIC PAINLEARN MORE ABOUT THE CONGRESS
URL:https://www.braincouncil.eu/event/health-gains-and-socio-economic-impacts-of-structured-interdisciplinary-management-of-chronic-primary-low-back-pain-iasp-2024-world-congress-on-pain/
LOCATION:Amsterdam\, The Netherlands
ATTACH;FMTTYPE=image/webp:https://www.braincouncil.eu/wp-content/uploads/2024/04/59ec1c1b87924a04983b63473d58d524_c6dd498835f30c6fce901dccefa94388.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240825
DTEND;VALUE=DATE:20240902
DTSTAMP:20260417T050743
CREATED:20240126T200053Z
LAST-MODIFIED:20240126T200718Z
UID:51933-1724544000-1725235199@www.braincouncil.eu
SUMMARY:Walking the Talk for Dementia 2024
DESCRIPTION:Walking the Talk for Dementia is an immersive experience that challenges conventional power dynamics and hierarchies in healthcare by using shared vulnerability as a catalyst for transformation. The second edition is set to take place from 25 August to 1 September 2024 in Santiago de Compostela (Spain). \nIt consists of a 40 km\, four-day walk along the Camino de Santiago de Compostela (Spain) for deepen connections and diversify perspectives\, followed by a two-day symposium to consolidate reflections and collaborations. \nParticipants include individuals working\, researching\, and living with dementia\, both inspired and affected by this diagnosis. Together we explore and highlight a variety of key issues related to dementia across social\, geographical\, cultural\, and professional backgrounds. \nVisit the websiteFind out moreFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/walking-the-talk-for-dementia-2024/
LOCATION:Santiago de Compostela\, Spain
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2024/01/WTD24_GOOGLEFORM_03.png
END:VEVENT
END:VCALENDAR